Clinical Trial

Testing Experimental Medication in Healthy Subjects

Study Description

A Study of Subcutaneously-administered Guselkumab Delivered by 3 Different Devices in Healthy Participants

The purpose of this study is to evaluate the serum concentration of guselkumab after administration using three different devices in healthy participants.

Location

Locations Selected Location

Methods

Pharmaceutical medication involved Pharmaceutical medication involved
Patients and healthy individuals accepted Patients and healthy individuals accepted

Drug - Guselkumab

Guselkumab will be administered subcutaneously.

Additional Information

Official Study Title

An Open-label, Randomized, Parallel-group Study to Assess the Pharmacokinetic Bioequivalence of Subcutaneously-administered Guselkumab Delivered by 3 Different Devices in Healthy Participants

Clinical Trial ID

NCT04147338

ParticipAid ID

bkREXa